CPhI North America is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.
Piet Christiaens (Scientific Director, Nelson Labs Europe)
Date: Thursday, September 10
Time: 2:00pm - 2:45pm
Pass Type: VIP Attendee, Exhibitor, Expo & Conference, Matchmaking, Student - Get your pass now!
Track: Drug Development & Delivery
Vault Recording: TBD
Organic Chromatographic “Screening” to discover, identify and quantify organic compounds in an extract or drug product is a relatively new concept to both the Pharmaceutical and Medical Device Industries. While the Chromatographic Screening process is the best solution to cover the three functions is should serve, each function of the screening process is prone to errors that are inherent to the screening methodology.
· The risk of omission: omitting a compound in chromatographic screening as fatal error
· The risk of inexact identification: mis-identifying a compound as fatal error
· The risk of inaccurate and imprecise quantitation in chromatographic screening processes.
The presentation will explain these errors in detail and how to minimize the occurrence of these errors